Cen Biotech Inc
CENBFDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001653821
Cen Biotech Inc was delisted in 2023; its insiders filed their last Form 4 on Apr 13, 2022; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
Holders of 5% or more of CENBF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cen Biotech Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Cen Biotech Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Cen Biotech Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 25, 2021 | Tarrabain Alex | 13D/AOld format | – | – | – | SEC |
| Jun 15, 2021 | Payne Brian | 13DOld format | – | New | – | SEC |
| Jun 15, 2021 | Chaaban Bahige B. | 13DOld format | – | New | – | SEC |
| Jun 15, 2021 | Tarrabain Alex | 13DOld format | – | New | – | SEC |
| Jun 15, 2021 | Byrne Joseph A. | 13DOld format | – | New | – | SEC |
| Jun 15, 2021 | Boswell Richard | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cen Biotech Inc shares.
No Form 144 notices for Cen Biotech Inc are on file.